"Low t," Testosterone Therapies and AndroGel cases
AndroGeland other “low T” therapies have recently been linked to cardio vascular problems in middle aged and older men with a history of heart disease. According to the Journal of the American Medical Association (JAMA) recent studies have determined that older men had a 29% higher incidence of stroke, heart attack and death when undergoing testosterone therapy.
In March 2015, the Food and Drug Administration (FDA) announced that all testosterone replacement therapies must have their labels updated to indicate that men using “low T” therapies are at an increased risk for heart attacks and strokes.
If you or a loved one has suffered heart failure and/or death, you may have a case for compensation for heart attack or stroke while on testosterone therapy.
The experienced lawyers at Davant & Associates will seek as much financial relief as possible for injured/damaged patients, and families of victims of heart failure while taking “low T” therapy. We will have your case reviewed as quickly as possible, and let you know whether we believe you have a case we are willing to pursue, usually within days of obtaining relevant medical records. Please contact Davant & Associates for a no obligation free case evaluation.